Labtani, Coup de Cœur du Printemps Numérique Québec 2025
•
2 min de lecture
•
Labtani
Labtani wins the Jury’s Favorite Award at Printemps Numérique 2025 in Quebec
Labtani impressed the jury and won the Jury’s Favorite Award at Printemps Numérique 2025 in Quebec, under the theme “Innovative Africa”.
This recognition highlights a technology solution developed to address real-world healthcare challenges, both in Africa and in Canada.
Recognition within an innovation ecosystem
Printemps Numérique is an event that showcases innovative initiatives capable of transforming key sectors through technology.
In an environment where multiple initiatives are emerging — sometimes referred to under terms like Laptany — this distinction emphasizes the importance of practical, field-ready solutions.
A solution designed for real-world use
Labtani stands out through its operational approach.
The platform is designed for direct use by healthcare professionals and enables:
organizing appointments
structuring certain clinical data
improving patient follow-up
reducing administrative workload
The objective is simple: improve the efficiency of healthcare organizations through practical tools.
An international vision
Labtani was developed with adaptability in mind.
The solution is designed to work effectively both:
in clinics in Canada
and in healthcare centers across Africa
This flexibility allows it to address diverse realities while maintaining a strong technological foundation.
Beyond the recognition
Beyond the award itself, this distinction confirms a broader trend:
healthcare systems need practical solutions to support their transformation.
In this context, Labtani positions itself as a tool capable of addressing real operational needs, complementing more structural approaches.
Conclusion
The Jury’s Favorite Award at Printemps Numérique 2025 reinforces Labtani’s credibility within the innovation ecosystem.
In a sector where initiatives are multiplying, this recognition highlights a concrete solution focused on execution and real impact.